.FDA denies experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Authorize MDMA Treatment, Seeking Additional Research Study The New York TimesFDA Rejects Ecstasy-Based Medicine The Commercial JournalFDA declines to permit novel MDMA treatment to manage post-traumatic stress disorder, with request for additional hearing information CNNFDA turns down first psychedelic to deal with post-traumatic stress disorder, requiring even more research The Washington Blog post.